The role of PTPN13 in invasion and metastasis of lung squamous cell carcinoma.
暂无分享,去创建一个
Wei Zhang | Wei Zhang | L. Gong | Shaojun Zhu | Shaojun Zhu | Xiujuan Han | Li Xue | Libin Zhou | Li Gong | Li Yao | Shumei Wang | Miao Lan | Yanhong Li | Lingyun Xue | Shu-mei Wang | Yan-hong Li | Libin Zhou | Xiu-juan Han | M. Lan | L. Yao
[1] M. Santoro,et al. Dysregulated RET signaling in thyroid cancer. , 2008, Endocrinology and metabolism clinics of North America.
[2] H. Stein,et al. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis , 2003, British Journal of Cancer.
[3] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[4] K. S. Erdmann. The protein tyrosine phosphatase PTP-Basophil/Basophil-like. Interacting proteins and molecular functions. , 2003, European journal of biochemistry.
[5] R. Stocco,et al. A novel protein-tyrosine phosphatase with homology to both the cytoskeletal proteins of the band 4.1 family and junction-associated guanylate kinases. , 1994, The Journal of biological chemistry.
[6] Ding‐Shinn Chen,et al. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] J. Minna,et al. Focus on lung cancer. , 2002, Cancer cell.
[8] M. Lacroix-Triki,et al. PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase. , 2010, Cancer research.
[9] C. Mountain,et al. The international system for staging lung cancer. , 2000, Seminars in surgical oncology.
[10] G. Viglietto,et al. The nonreceptor-type tyrosine phosphatase PTPN13 is a tumor suppressor gene in non-small cell lung cancer. , 2012, The American journal of pathology.
[11] TNM: CLASSIFICATION OF MALIGNANT TUMOURS , 1969 .
[12] John D Minna,et al. New molecularly targeted therapies for lung cancer. , 2007, The Journal of clinical investigation.
[13] J. Yates,et al. Protein tyrosine phosphatase PTPN13 negatively regulates Her2/ErbB2 malignant signaling , 2008, Oncogene.
[14] Neil O. Carragher,et al. The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.
[15] P G Drake,et al. Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.
[16] A. Gazdar. Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapy , 2010, Cancer and Metastasis Reviews.
[17] G. F. Harris,et al. The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth , 2007, Journal of Virology.
[18] D. Schlaepfer,et al. Control of motile and invasive cell phenotypes by focal adhesion kinase. , 2004, Biochimica et biophysica acta.
[19] K. Alitalo,et al. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. , 2009, Current opinion in cell biology.
[20] Wolfgang Link,et al. The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. , 2008, Current cancer drug targets.
[21] Pier Paolo Pandolfi,et al. Tenets of PTEN Tumor Suppression , 2008, Cell.
[22] T. Hunter,et al. Oncogenic kinase signalling , 2001, Nature.
[23] C. Sawyers,et al. Targeted cancer therapy , 2004, Nature.
[24] J. Guan,et al. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. , 2011, Advanced drug delivery reviews.
[25] G. Carpenter,et al. ErbB receptors: new insights on mechanisms and biology. , 2006, Trends in cell biology.
[26] D. Carter. TNM Classification of Malignant Tumors , 1998 .
[27] Ji Luo,et al. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism , 2006, Nature Reviews Genetics.
[28] P. Massion,et al. Expression of focal adhesion kinase in small‐cell lung carcinoma , 2012, Cancer.
[29] N. Yoo,et al. Mutational analysis of FLASH and PTPN13 genes in colorectal carcinomas , 2008, Pathology.
[30] B. Ylstra,et al. Genomic Profiles Associated with Early Micrometastasis in Lung Cancer: Relevance of 4q Deletion , 2009, Clinical Cancer Research.
[31] F. Révillion,et al. Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer , 2009, International journal of cancer.
[32] Paolo P. Provenzano,et al. The role of focal adhesion kinase in tumor initiation and progression , 2009, Cell adhesion & migration.
[33] Fang Fan,et al. Cancer Grading Manual , 2007 .
[34] S. Hanks,et al. The Signaling and Biological Implications of FAK Overexpression in Cancer , 2006, Clinical Cancer Research.
[35] Giovanni Parmigiani,et al. Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.